Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review-Reference-Cited by-同舟云学术

Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review

Published:2020-06-24 Issue:7 Volume:81 Page:837-858
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Prasher Parteek¹²^ORCID,Sharma Mousmee¹³,Aljabali Alaa A. A.⁴,Gupta Gaurav⁵^ORCID,Negi Poonam⁶,Kapoor Deepak N.⁶,Singh Inderbir⁷,Zacconi Flavia C.⁸,Jesus Andreoli Pinto Terezinha⁹,Silva Mateus Webba¹⁰,Bakshi Hamid A.¹⁰,Chellappan Dinesh Kumar¹¹,Tambuwala Murtaza M.¹⁰^ORCID,Dua Kamal⁶¹²¹³¹⁴

Affiliation:

1. UGC‐Sponsored Centre for Advanced Studies, Department of Chemistry Guru Nanak Dev University Amritsar India

2. Department of Chemistry University of Petroleum & Energy Studies Dehradun India

3. Department of Chemistry Uttaranchal University Dehradun India

4. Department of Pharmaceutics and Pharmaceutical Technology Faculty of Pharmacy, Yarmouk University Irbid Jordan

5. School of Pharmacy Suresh Gyan Vihar University Jaipur India

6. School of Pharmaceutical Sciences Shoolini University of Biotechnology and Management Sciences Solan India

7. Chitkara College of Pharmacy Chitkara University Punjab India

8. Departamento de Organica, faculdad de Quimica y de Farmacia, Pontificia Universidad Catolica de Chile Santiago Chile

9. Department of Pharmacy, Faculty of Pharmaceutical Sciences University of Sao Paulo Brazil

10. School of Pharmacy and Pharmaceutical Science Ulster University Coleraine United Kingdom

11. Department of Life Sciences, School of Pharmacy International Medical University Kuala Lumpur Malaysia

12. Discipline of Pharmacy, Graduate School of Health University of Technology Sydney Sydney New South Wales Australia

13. Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy University of Newcastle Callaghan New South Wales Australia

14. Centre for Inflammation, Centenary Institute Royal Prince Alfred Hospital Sydney New South Wales Australia

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21704

Reference113 articles.

1. Small hybrid heteroaromatics: resourceful biological tools in cancer research

2. Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?

3. Combination Therapy Strategies for the Treatment of Malaria

4. Polypharmacology: Challenges and Opportunities in Drug Discovery

5. The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation;Pathology - Research and Practice;2024-09

2. Synthesis, biological activity, X-ray crystallographic, DFT calculations and molecular dynamics simulation studies of 2-phenylthiazole-1,3,5-triazine derivatives as potential cholinesterase inhibitors;Journal of Molecular Structure;2024-08

3. Synthesis and hypoglycemic activity of new nicotinonitrile-furan molecular hybrids;Биоорганическая химия;2024-04-15

4. Synthesis and Hypoglycemic Activity of New Nicotinonitrile-Furan Molecular Hybrids;Russian Journal of Bioorganic Chemistry;2024-04

5. Boronate affinity/hydrophobic charge induction synergistic adsorption for improving purification of antibody;Chemical Engineering Journal;2024-03